Liposomal amphotericin B (ambisome) cures nearly 100% of cases of visceral leishmaniasis and has become the drug of choice for antimonial-resistant disease. Likely due to pharmacokinetic considerations, it is not useful against cutaneous or mucosal leishmaniasis. The recommended dose for the treatment of visceral leishmaniasis is 3 mg/kg/day intravenously for days 1—5, 14, and 21, with the dose being increased to 4 mg/kg and extended to days 1—5, 10, 17, 24, 31, and 38 for immunosuppressed patients. Shorter courses of the drug provide a lower-cost alternative. Cure rates are ~90% with either regimen.

101 Power Tips For Preventing and Treating Headaches

101 Power Tips For Preventing and Treating Headaches

Are you fed up with your frequent headache pain? 101 Simple Ways to Attack Your Headache BEFORE the Pain Starts Guaranteed No Pain, No Fear, Full Control Normal Life Again Headaches can stop you from doing all the things you love. Seeing friends, playing with the kids... even trying to watch your favorite television shows.

Get My Free Ebook

Post a comment